Sol-Gel Technologies
SLGL • NASDAQ
Sol-Gel Technologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Moshe Arkin, with a market cap of $180.2M.
CEOMoshe Arkin
Next Earnings
Upcoming earnings announcement for Sol-Gel Technologies
Date
Tuesday, April 28, 2026 (in 3 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
$0.39
Revenue Estimate
$6.5M
Earnings History
Past 12 earnings reports for Sol-Gel Technologies
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 20, 2025 | Q3 2025 | -$2.13Est: -$2.09 | -1.9% | $400.0KEst: $300.0K | +33.3% | — |
| Aug 15, 2025 | Q2 2025 | $4.17 | — | $17.3M | — | — |
| May 23, 2025 | Q1 2025 | -$3.20Est: -$0.12 | -2566.7% | $1.0MEst: $1.2M | -14.1% | — |
| Apr 29, 2025 | Q4 2024 | -$0.21Est: -$0.11 | -90.9% | $278.0KEst: $2.0M | -86.1% | — |
| Nov 15, 2024 | Q3 2024 | -$0.01Est: -$0.13 | +92.3% | $5.4MEst: $2.7M | +99.3% | — |
| Aug 16, 2024 | Q2 2024 | $0.07Est: -$0.20 | +135.0% | $5.4MEst: $1.1M | +417.4% | — |
| May 20, 2024 | Q1 2024 | -$0.23Est: -$0.15 | -53.3% | $466.0KEst: $1.3M | -64.2% | — |
| Mar 13, 2024 | Q4 2023 | -$0.17Est: -$0.17 | 0.0% | $447.0KEst: $270.0K | +65.6% | — |
| Nov 9, 2023 | Q3 2023 | -$0.21Est: -$0.23 | +8.7% | $213.0KEst: $690.0K | -69.1% | — |
| Aug 10, 2023 | Q2 2023 | -$0.22Est: -$0.25 | +12.0% | $594.0KEst: $1.6M | -61.7% | — |
| May 12, 2023 | Q1 2023 | -$0.41Est: -$0.21 | -95.2% | $758.0KEst: $470.0K | +61.3% | — |
| Mar 10, 2023 | Q4 2022 | -$0.25Est: -$0.12 | -108.3% | $100.0KEst: $1.8M | -94.6% | — |